Is Osimertinib Better Alone or With Chemotherapy in Non–Small Cell Lung Cancer?

Medscape

Center

High Factuality

Private Equity: Kohlberg Kravis Roberts

Is Osimertinib Better Alone or With Chemotherapy in Non–Small Cell Lung Cancer?

A new study reveals that baseline EGFR mutations may be key to making the decision in the frontline setting. Medscape Medical News